Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
-
New acne gel studied for younger kids: could it clear up moderate to severe breakouts?
Disease control Not yet recruitingThis study is testing a gel called CABTREO, which combines three acne-fighting ingredients (clindamycin, adapalene, and benzoyl peroxide), in children aged 9 to 11 with moderate to severe acne. The goal is to see if it is safe and works well over 12 weeks. About 100 kids will app…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New foam treatment could help kids with colitis avoid stronger drugs
Disease control Not yet recruitingThis study tests a steroid foam (budesonide) given rectally to children aged 5 to 17 with mild to moderate ulcerative colitis in the lower colon. The goal is to see if it can safely induce remission after 6 weeks of treatment. About 100 children will receive either a low dose, hi…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC
-
New hope for young minds: depression drug trial for children
Symptom relief Not yet recruitingThis study tests whether bupropion hydrobromide (Aplenzin) can safely ease depression symptoms in children and adolescents aged 7 to 17. About 246 participants will receive either the drug or a placebo. The main goal is to see if depression scores improve by the end of treatment.
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 18:44 UTC